Jenburkt Pharmaceuticals Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
304.27 Cr.
|
P/BV
|
2.49
|
Book Value (Rs.)
|
277.32
|
52 Week High/Low (Rs.)
|
925/587
|
FV/ML
|
10/1
|
P/E(X)
|
12.37
|
Bookclosure
|
26/07/2023
|
EPS (Rs.)
|
55.76
|
Div Yield (%)
|
2.09
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | 22.30 | 16.50 | 21.14 | 26.63 |
| | | | | |
Net CashFlow From Operating Activities | 0.00 | 9.40 | 18.03 | 15.02 | 12.99 |
Net Cash Used In Investing Activities | 0.00 | -1.33 | -18.78 | -2.88 | -10.53 |
Net Cash Used From Financing Activities | 0.00 | -5.53 | 0.71 | -10.83 | -2.42 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 2.54 | -0.04 | 1.31 | 0.04 |
Cash And Cash Equivalents Begin of Year | 0.00 | 2.49 | 2.53 | 1.23 | 1.18 |
Cash And Cash Equivalents End Of Year | 0.00 | 5.03 | 2.49 | 2.53 | 1.23 |